Inventor · disambiguated record
Ying Tang
Also filed as: TANG YING · TANG YING-SHENG
31 granted patents·14 pending applications·430 citations·filing 2001–2024
97Inventor score
Files withLILLY CO ELI18CELL MATRIX INC5LEUNG DONMIENNE DOEN MUN4DAVIES JULIAN3APPLIED MOLECULAR EVOLUTION2
Top patents by PatentIndex Score
45 records- 0196US11078261B2Anti-N3pGlu amyloid beta peptide antibodies and uses thereofLILLY CO ELI·Filed 2020·Granted Aug 3, 2021·4 cites·9 claims
- 0295US7740847B2Variant Fc regionsAPPLIED MOLECULAR EVOLUTION·Filed 2005·Granted Jun 22, 2010·68 cites·13 claims
- 0395US7619069B2Antibodies to TGF-beta 1LILLY CO ELI·Filed 2007·Granted Nov 17, 2009·34 cites·13 claims
- 0494US10647759B2Anti-N3pGlu amyloid beta peptide antibodies and uses thereofLILLY CO ELI·Filed 2018·Granted May 12, 2020·14 cites·15 claims
- 0594US8961972B2Anti-N3pGlu amyloid beta peptide antibodies and uses thereofLILLY CO ELI·Filed 2013·Granted Feb 24, 2015·24 cites·12 claims
- 0694US8679498B2Anti-N3PGLU amyloid beta peptide antibodies and uses thereofLU JIRONG·Filed 2011·Granted Mar 25, 2014·45 cites·9 claims
- 0794US8623365B2Aβ binding moleculesDAVIES JULIAN·Filed 2011·Granted Jan 7, 2014·13 cites·16 claims
- 0894US7354584B2Recombinant IL-9 antibodiesMEDIMMUNE INC·Filed 2004·Granted Apr 8, 2008·50 cites·9 claims
- 0993US8110191B2Anti-IL-17 antibodiesALLAN BARRETT·Filed 2010·Granted Feb 7, 2012·44 cites·3 claims
- 1092US9944696B2Anti-N3pGlu amyloid beta peptide antibodies and uses thereofLILLY CO ELI·Filed 2017·Granted Apr 17, 2018·13 cites·19 claims
- 1191US7566770B2Humanized collagen antibodies and related methodsCELL MATRIX INC·Filed 2006·Granted Jul 28, 2009·12 cites·11 claims
- 1289US8183346B2Anti-ferroportin 1 monoclonal antibodies and uses thereofLEUNG DONMIENNE DOEN MUN·Filed 2009·Granted May 22, 2012·17 cites·7 claims
- 1389US7820163B2Anti-hepcidin antibodies and uses thereofLILLY CO ELI·Filed 2008·Granted Oct 26, 2010·11 cites·9 claims
- 1489US7365167B2Humanized collagen antibodies and related methodsCELL MATRIX INC·Filed 2001·Granted Apr 29, 2008·21 cites·21 claims
- 1587US7575747B2Aβ binding moleculesAPPLIED MOLECULAR EVOLUTION·Filed 2004·Granted Aug 18, 2009·10 cites·5 claims
- 1686US7390885B2Humanized collagen antibodies and related methodsCELL MATRIX INC·Filed 2001·Granted Jun 24, 2008·11 cites·21 claims
- 1785US7763247B2Humanized collagen antibodies and related methodsCELL MATRIX INC·Filed 2008·Granted Jul 27, 2010·6 cites·9 claims
- 1884US8609817B2Anti-hepcidin-25 selective antibodies and uses thereofLEUNG DONMIENNE DOEN MUN·Filed 2009·Granted Dec 17, 2013·9 cites·17 claims
- 1982US9328173B2Multifunctional antibodies binding to EGFR and METLILLY CO ELI·Filed 2014·Granted May 3, 2016·7 cites·8 claims
- 2081US8105597B2Aβ binding moleculesDAVIES JULIAN·Filed 2009·Granted Jan 31, 2012·3 cites·7 claims
- 2177US8679497B2Anti-ferroportin 1 monoclonal antibodies and uses thereofLEUNG DONMIENNE DOEN MUN·Filed 2012·Granted Mar 25, 2014·2 cites·20 claims
- 2276US9580499B2VEGFR2/Ang2 compoundsLILLY CO ELI·Filed 2015·Granted Feb 28, 2017·2 cites·10 claims
- 2375US8765129B2Anti-hepcidin antibodies and uses thereofLILLY CO ELI·Filed 2012·Granted Jul 1, 2014·2 cites·5 claims
- 2474US8329174B2Anti-hepcidin antibodies and uses thereofLEUNG DONMIENNE DOEN MUN·Filed 2010·Granted Dec 11, 2012·2 cites·9 claims
- 2573US9416182B2Anti-TNF-anti-IL-17 bispecific antibodiesLILLY CO ELI·Filed 2014·Granted Aug 16, 2016·2 cites·6 claims
- 2673US7763248B2Humanized collagen antibodies and related methodsCELL MATRIX INC·Filed 2008·Granted Jul 27, 2010·1 cites·8 claims
- 2771US8481037B2Recombinant IL-9 antibodies and uses thereofREED JENNIFER LYNNE·Filed 2011·Granted Jul 9, 2013·2 cites·16 claims
- 2869US2021371509A1ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOFLILLY CO ELI·Filed 2021·Application pending·0 cites
- 2967US9932397B2VEGFA/Ang2 CompoundsLILLY CO ELI·Filed 2016·Granted Apr 3, 2018·1 cites·16 claims
- 3065US8128927B2Methods of using TGF-β 1 binding compositionsDAVIES JULIAN·Filed 2009·Granted Mar 6, 2012·0 cites·8 claims
- 3165US2025127772A1Specific tetradentate copper chelators for the treatment of wilson's diseaseUNIV GUANGDONG TECHNOLOGY·Filed 2024·Application pending·0 cites
- 3262US2024173425A1Human cd33 antibodies and glucocorticoid conjugatesLILLY CO ELI·Filed 2023·Application pending·0 cites
- 3361US2009047277A1Recombinant il-9 antibodies and uses thereofMEDIMMUNE INC·Filed 2007·Application pending·0 cites
- 3459US2013273071A1Recombinant IL-9 Antibodies And Uses ThereofMEDIMMUNE LLC·Filed 2013·Application pending·0 cites
- 3559US2010303726A1Humanized collagen antibodies and related methodsCELLMATRIX·Filed 2010·Application pending·0 cites
- 3657US2024391992A1Antibodies targeting xcl1 and methods of using the sameLILLY CO ELI·Filed 2024·Application pending·0 cites
- 3756US2022281975A1Trem2 antibodies and uses thereofLILLY CO ELI·Filed 2022·Application pending·0 cites
- 3850US2024229166A9Methods of stratifying and treating coronavirus infectionMASSACHUSETTS INST TECHNOLOGY·Filed 2022·Application pending·0 cites
- 3948US12459993B2Anti-alpha-synuclein antibodies and uses thereofLILLY CO ELI·Filed 2019·Granted Nov 4, 2025·0 cites·25 claims
- 4048US2023321108A1Unit dosage composition of akt inhibitorNANJING CHIA TAI TIANQING PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 4146US2019388009A1Assessing nerve conduction in response to an oral care compositionPROCTER & GAMBLE·Filed 2019·Application pending·0 cites
- 4245US2017121411A1VEGFR2/Ang2 CompoundsLILLY CO ELI·Filed 2017·Application pending·0 cites
- 4342US2008089892A1Fc Region VariantsLILLY CO ELI·Filed 2005·Application pending·0 cites
- 4439US10093706B2Dominant positive hnRNP-E1 polypeptide compositions and methodsUNIV INDIANA RES & TECH CORP·Filed 2017·Granted Oct 9, 2018·0 cites·13 claims
- 4537US2010260752A1Opsonic and protective antibodies specific for lipoteichoic acid of gram positive bacteriaBIOSYNEXUS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ying Tang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →